Human umbilical cord mesenchymal stem cells (Bellastem Biotechnology)

人脐带间充质干细胞（兴瑞生物）

Report date: 2023/03/29 15:53:12

Base Information

Drug NameHuman umbilical cord mesenchymal stem cells (Bellastem Biotechnology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBellastem Biotechnology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBellastem Biotechnology Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A